Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients Balazs GyörffyReinhold Schäfer Preclinical Study 05 December 2008 Pages: 433 - 441
Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor α (ERα) in tissue microarrays of ERα positive human breast carcinomas George P. SklirisBrian G. RowanLeigh C. Murphy Preclinical Study 23 December 2008 Pages: 443 - 453
Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR Anieta M. SieuwertsJaco KraanJohn A. Foekens Preclinical Study 30 December 2008 Pages: 455 - 468
Opposite effects of protein kinase C beta1 (PKCβ1) and PKCε in the metastatic potential of a breast cancer murine model Valeria C. GrossoniLaura B. TodaroAlejandro J. Urtreger Preclinical Study 09 January 2009 Pages: 469 - 480
A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines Alan MackayNarinder TamberAlan Ashworth Preclinical Study 24 January 2009 Pages: 481 - 498
Stimulation of the bradykinin B1 receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway Luis MolinaCarola E. MatusMaria T. Poblete Preclinical Study 28 January 2009 Pages: 499 - 510
Reporting of race and ethnicity in breast cancer research: room for improvement Kelly W. MitchellLisa A. CareyJeffrey Peppercorn Clinical trial 15 May 2009 Pages: 511 - 517
‘Minority report’: how best to analyze clinical trial data to address disparities Dawn L. HershmanJoseph M. Unger Invited commentary 17 September 2009 Pages: 519 - 521
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients Marta PestrinSilvia BessiAngelo Di Leo Clinical trial 12 July 2009 Pages: 523 - 530
Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users A. S. DieudonnéD. LambrechtsP. Neven Clinical trial 12 July 2009 Pages: 531 - 538
Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence P. ShahM. RosenS. M. Domchek Clinical trial 17 July 2009 Pages: 539 - 546
Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling Julie LemieuxCarl AmireaultElizabeth Maunsell Epidemiology 25 February 2009 Pages: 547 - 552
Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status Min ZhangHongjian YangC. D’Arcy J. Holman Epidemiology 28 February 2009 Pages: 553 - 563
Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk Daniele CampaJames McKayRudolf Kaaks Epidemiology 28 February 2009 Pages: 565 - 574
No evidence of familial correlation in breast cancer metastasis Alice S. WhittemoreBeth StearmanSaundra S. Buys Epidemiology 19 March 2009 Pages: 575 - 581
Accuracy of self-reported breast cancer among women undergoing mammography Linn AbrahamBerta M. GellerDiana L. Miglioretti Epidemiology 20 March 2009 Pages: 583 - 592
Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study Mike G. MartinJohn S. WelchMatthew J. Walter Epidemiology 26 March 2009 Pages: 593 - 598
STK15 F31I polymorphism is associated with breast cancer risk: a meta-analysis involving 25,014 subjects Li-Xin QiuBo ChenXi-Chun Hu Epidemiology 13 October 2009 Pages: 599 - 603
Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERα Le LamXiuying HuManijeh Pasdar Brief Report 11 November 2008 Pages: 605 - 621
Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality? F. DidierD. RadiceJ. Y. Petit Brief Report 12 November 2008 Pages: 623 - 633
Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care Christopher L. TebbitJun ZhaiJohn A. Olson Jr. Report 18 February 2009 Pages: 635 - 643
Genomic analysis from tissue core biopsies: standard of care for the future? Sudipa SarkarDavid P. TuckLyndsay N. Harris Invited Commentary 21 February 2009 Pages: 645 - 646
Caution regarding genotyping methodology for a tri-allelic polymorphism in the novel breast cancer susceptibility gene NQO2 Ke-Da YuGen-Hong DiZhi-Ming Shao Letter to the editor 03 June 2009 Pages: 647 - 649
Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer Najim AmezianeAns M. W. van den OuwelandQuinten Waisfisz Letter to the editor 06 June 2009 Pages: 651 - 653
The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features E. BarrosoG. PitaG. Ribas Letter to the Editor 18 June 2009 Pages: 655 - 660
The immunohistochemically “ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative” subgroup is not a surrogate for the normal-like subtype in breast cancer Ke-Da YuZhen-Zhou ShenZhi-Ming Shao Letter to the editor 28 August 2009 Pages: 661 - 663
